参考文献/References:
[1]Quiat D,Kula T,Shimizu C,et al. Unbiased screening of Kawasaki disease sera for viral antigen exposure[J]. Open Forum Infect Dis,2017,4(suppl_1):S684-S685.
[2]Thumjaa A,Selvakumar C. Atypical Kawasaki disease[J]. Harefuah,2017,64(3):100-102.
[3]覃艺玉.川崎病的研究进展[J].临床医药文献电子杂志,2017,4(90):17814-17815.
[4]周倩沁,吴军华,邱海燕. 川崎病病因及发病机制的研究进展[J]. 浙江医学,2019,41(13):1443-1446.
[5] Huang SM, Huang SH, Weng KP,et al. Update on association between Kawasaki disease and infection[J].?J Chin Med Assoc,2019,82(3):172–174.
[6]李瑞燕,李晓辉. 川崎病病因学研究进展 [J]. 心血管病学进展 ,2010,31(4):616-620.
[7]Yamashiro Y,Nagata S,Ohtsuka Y,et al. Microbiologic studies on the small intestine in Kawasaki disease[J]. Pediatr Res,1996,39(4 Pt 1):622-624.
[8]Eladawy M,Dominguez SR ,Anderson MS,et al. Kawasaki disease and the pediatric gastroenterologist:a diagnostic challenge[J]. J Pediatr Gastroenterol Nutr,2013,56(3):297-299.
[9]Esposito S,Polinori I,Rigante D. The gut microbiota-host partnership as a potential driver of Kawasaki syndrome[J]. Front Pediatr,2019,34(7):124-126.
[10]Monedero V,Buesa J,Rodríguez-Díaz J. The interactions between host glycobiology,bacterial microbiota,and viruses in the gut[J]. Viruses,2018,10(2):96.
[11]B?ckhed F,Roswall J,Peng Y,et al. Dynamics and stabilization of the human gut microbiome during the first year of life[J]. Cell Host Microbe,2015,17( 6):852.
[12]Koenig JE,Spor A,Scalfone N,et al. Succession of microbial consortia in the developing infant gut microbiome[J]. Proc Natl Acad Sci U S A ,2011,108 suppl 1(suppl 1):4578-4585.
[13]Chen SY,Tsai CN,Lee SY,et al. Intestinal microbiome in children with severe and complicated acute viral gastroenteritis[J]. Sci Rep,2017 (7):46130.
[14]Motta JP,Allain T,Green-Harrison LE,et al. Iron sequestration in microbiota biofilms as a novel strategy for treating inflammatory bowel disease[J]. Inflamm Bowel Dis,2018,24(7):1493-1502.
[15]Lee YK,Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system?[J]. Science,2010,330(6012):1768-1773.
[16]Aguilera M,Cerdà-Cuéllar,M,Martínez,V. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice[J]. Gut Microbes,2015,6(1):10-23.
[17]Rigante D,Tarantino G,Valentini P. Non-infectious makers of Kawasaki syndrome:tangible or elusive triggers?[J]. Immunol Res,2016,64(1):51-54.
[18]张胜,梁雪. 川崎病治疗研究进展[J]. 国际儿科学杂志,2018,45(8):584-588.
[19]Rowley,Anne H.The etiology of Kawasaki Disease:A conventional infectious agent[J]. Progress in Pediatric Cardiology ,2004,19(2):109-113.
[20]Bressieux-Degueldre S,Schaffner D,Hofer M,et al. Kawasaki disease:an update[J]. Rev Med Suisse,2018,14(594):384-389.
[21]Nagata S,Yamashiro Y,Ohtsuka Y,et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease[J]. Immunology,2009,128(4):511-520.
[22]Nagata S,Yamashiro Y Maeda M,et al. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease[J]. Pediatr Res,1993,33(6):557-563.
[23]Hooper LV,Wong MH,Thelin A,et al. Molecular analysis of commensal host-microbial relationships in the intestine[J]. Science,2001,291(5505):881-884.
[24]Wang H,Gong J,Wang W,et al. Are There any different effects of Bifidobacterium,Lactobacillus and Streptococcus on intestinal sensation,barrier function and intestinal immunity in PI-IBS mouse model?[J]. PLoS One,2014,9(3):e90153.
[25]Reading NC,Kasper DL. The starting lineup:key microbial players in intestinal immunity and homeostasis[J]. Front Microbiol,2011,2:148.
[26]Fernandez EM,Valenti V,Rockel C,et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide[J]. Gut,2011,60(8):1050-1059.
[27]Takeshita S,Kobayashi I,Kawamura Y,et al. Characteristic profile of intestinal microflora in Kawasaki disease[J]. Acta Paediatr,2002,91(7):783-788.
[28]Takeshita S,Tsujimoto H,Kawase H,et al. Increased levels of lipopolysaccharide binding protein in plasma in children with kawasaki disease[J]. Clin Diagn Lab Immunol,2002,9(1):205-206.
[29]Nagata S,Yamashiro Y,Ohtsuka Y,et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease[J]. Immunology,2009,128(4):511-520.
[30]沈男,刘毅,盖中涛. 肠道菌群与肠道疾病关系的研究进展[J]. 基础医学与临床,2018,38(7):1034-1037.
[31]Sobhonslidsuk A,Chanprasertyothin S,Pongrujikorn T,et al. The association of gut microbiota with nonalcoholic steatohepatitis in Thais[J]. Biomed Res Int,2018,2018:9340316.
[32]王晨,钟赛意,邹宇晓. 膳食纤维经肠道微生态途径调节脂质代谢作用的研究进展[J]. 食品科学,2019,40(3):347-356..
[33]Motta JP,Allain T,Green-Harrison LE,et al. Iron sequestration in microbiota biofilms as a novel strategy for treating inflammatory bowel disease[J]. Inflamm Bowel Dis,2018,24(7):1493-1502.
[34]Tyagi AM,Yu M,Darby TM,et al. The microbial metabolite butyrate stimulates bone formation via t regulatory cell-mediated regulation of WNT10B expression[J]. Immunity,2018,49(6):1116–1131.e7.
[35]吴少辉,魏远安,吴嘉仪,等.益生元精准化研究进展[J].食品科学,2018,39(9):333-340.
[36]Barratt MJ,Lebrilla C,Shapiro HY,et al. The gut microbiota,food science,and human nutrition:a timely marriage[J]. Cell Host Microbe,2017,22(2):134-141.
[37]张庆,李晓静. 川崎病的治疗现状[J]. 心血管病学进展 ,2010,31(5):766-769.
[38]Hedrich CM,Schnabel A,Hospach T. Kawasaki disease[J]. Front Pediatr,2018,6:198.
相似文献/References:
[1]杨再英,王钰.川崎病后无创检查评估血管内皮功能的研究进展[J].心血管病学进展,2019,(6):939.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.025]
YANG Zaiying,WANG Yu.Non-invasive Assessment of Vascular Endothelial Function after Kawasaki Disease[J].Advances in Cardiovascular Diseases,2019,(6):939.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.025]
[2]魏伟 魏灵睿 冷辉.血清miR-1和miR-26水平与川崎病患儿的关系及其对冠状动脉损伤的评估价值[J].心血管病学进展,2021,(5):476.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.021]
WEI WeiWEI LingruiLENG Hui.Relationship Between Serum miR-1 and miR-26 Levels and Kawasaki Disease in Children and Its Value in Evaluating Coronary Artery Injury[J].Advances in Cardiovascular Diseases,2021,(6):476.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.021]
[3]王琼琼,赵胜.血小板活化在川崎病中的研究进展[J].心血管病学进展,2021,(6):552.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.000]
WANG QiongqiongZHAO Sheng.Platelet Activation in the Pathogenesis of Kawasaki Disease[J].Advances in Cardiovascular Diseases,2021,(6):552.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.000]
[4]李红霞 朱凯 刘雯 王慧 杨涛毅.0～5岁川崎病儿童静脉注射免疫球蛋白耐药的相关因素分析及预测模型构建[J].心血管病学进展,2023,(3):283.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.020]
LI HongxiaZHU KaiLIU WenWANG HuiYANG Taoyi?/html>.Analysis of Related Factors and Prediction Model?f Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease Aged 0 5 Years[J].Advances in Cardiovascular Diseases,2023,(6):283.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.020]
[5]王慧 张燕平 王志强 陈桂华 谢江.基于孟德尔随机化探索肠道菌群与儿童川崎病之间的因果关系[J].心血管病学进展,2023,(6):572.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.020]
WANG HuiZHANG Yanping,WANG Zhiqiang,CHEN Guihua,et al.To Explore the Causal Relationship Between Gut Microbiota and Kawasaki Disease in Children Based on Mendelian Randomization[J].Advances in Cardiovascular Diseases,2023,(6):572.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.020]
[6]张威 段高羊 郭瑶 唐明生 吴沣芝 蒋丰智.川崎病急性期中性粒细胞胞外诱捕网与血管损伤的相关研究[J].心血管病学进展,2024,(11):1046.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.018]
ZHANG Wei,DUAN Gaoyang,GUO Yao,et al.A Preliminary Study of the Involvement of Neutrophil Extracellular Traps on Vascular Injury in the Acute Phase of Kawasaki Disease[J].Advances in Cardiovascular Diseases,2024,(6):1046.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.018]